PL1828148T3 - Triazol podstawiony związkami aminobenzofenonu - Google Patents
Triazol podstawiony związkami aminobenzofenonuInfo
- Publication number
- PL1828148T3 PL1828148T3 PL05804019T PL05804019T PL1828148T3 PL 1828148 T3 PL1828148 T3 PL 1828148T3 PL 05804019 T PL05804019 T PL 05804019T PL 05804019 T PL05804019 T PL 05804019T PL 1828148 T3 PL1828148 T3 PL 1828148T3
- Authority
- PL
- Poland
- Prior art keywords
- triazole substituted
- aminobenzophenone compounds
- substituted aminobenzophenone
- compounds
- triazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63500004P | 2004-12-13 | 2004-12-13 | |
DKPA200401942 | 2004-12-16 | ||
EP05804019A EP1828148B1 (en) | 2004-12-13 | 2005-11-28 | Triazole substituted aminobenzophenone compounds |
PCT/DK2005/000757 WO2006063585A1 (en) | 2004-12-13 | 2005-11-28 | Triazole substituted aminobenzophenone compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1828148T3 true PL1828148T3 (pl) | 2010-08-31 |
Family
ID=37715934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05804019T PL1828148T3 (pl) | 2004-12-13 | 2005-11-28 | Triazol podstawiony związkami aminobenzofenonu |
Country Status (23)
Country | Link |
---|---|
US (1) | US8293772B2 (pl) |
EP (1) | EP1828148B1 (pl) |
JP (1) | JP5015005B2 (pl) |
KR (1) | KR101260236B1 (pl) |
CN (1) | CN101115728B (pl) |
AR (1) | AR051792A1 (pl) |
AT (1) | ATE455768T1 (pl) |
AU (1) | AU2005316034B2 (pl) |
BR (1) | BRPI0518993A2 (pl) |
CA (1) | CA2590479A1 (pl) |
DE (1) | DE602005019093D1 (pl) |
DK (1) | DK1828148T3 (pl) |
ES (1) | ES2341473T3 (pl) |
HR (1) | HRP20100225T1 (pl) |
IL (1) | IL183513A0 (pl) |
MX (1) | MX2007006739A (pl) |
NO (1) | NO20073574L (pl) |
PL (1) | PL1828148T3 (pl) |
PT (1) | PT1828148E (pl) |
RU (1) | RU2394818C2 (pl) |
UA (1) | UA90698C2 (pl) |
WO (1) | WO2006063585A1 (pl) |
ZA (1) | ZA200704809B (pl) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2346646T5 (es) * | 2002-05-30 | 2018-02-15 | The Scripps Research Institute | Ligación catalizada con cobre de azidas y acetilenos |
WO2007148074A1 (en) * | 2006-06-21 | 2007-12-27 | Hammersmith Imanet Limited | Chemical methods and apparatus |
US8080540B2 (en) | 2006-09-19 | 2011-12-20 | Abbott Products Gmbh | Therapeutically active triazoles and their use |
KR100932093B1 (ko) | 2006-09-27 | 2009-12-16 | 주식회사종근당 | 미세소관 형성 저해제로서 유용한 벤조페논 유도체 |
US8288367B2 (en) | 2006-11-30 | 2012-10-16 | Solvay Pharmaceuticals Gmbh | Substituted estratriene derivatives as 17BETA HSD inhibitors |
ATE520689T1 (de) * | 2007-12-18 | 2011-09-15 | Actelion Pharmaceuticals Ltd | Aminotriazolderivate als alx-agonisten |
CA2719243C (en) * | 2008-03-26 | 2013-06-25 | Chong Kun Dang Pharmaceutical Corp. | Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same |
US8822513B2 (en) | 2010-03-01 | 2014-09-02 | Gtx, Inc. | Compounds for treatment of cancer |
US9447049B2 (en) | 2010-03-01 | 2016-09-20 | University Of Tennessee Research Foundation | Compounds for treatment of cancer |
US9029408B2 (en) | 2008-06-16 | 2015-05-12 | Gtx, Inc. | Compounds for treatment of cancer |
DK2959900T3 (en) | 2008-06-16 | 2017-06-26 | Univ Tennessee Res Found | CONNECTION TO TREATMENT OF CANCER |
JP5732471B2 (ja) | 2009-12-22 | 2015-06-10 | レオ ファーマ アクティーゼルスカブ | 溶媒混合物およびビタミンd誘導体から成る医薬品組成物または類似体 |
ES2523119T3 (es) | 2009-12-22 | 2014-11-21 | Leo Pharma A/S | Nanocristales de monohidrato de calcipotriol |
AU2010335654B2 (en) | 2009-12-22 | 2015-04-09 | Leo Pharma A/S | Cutaneous composition comprising vitamin D analogue and a mixture of solvent and surfactants |
EP3064204A1 (en) | 2010-03-01 | 2016-09-07 | GTx, Inc. | Compounds for treatment of cancer |
US8912184B1 (en) | 2010-03-01 | 2014-12-16 | Alzheimer's Institute Of America, Inc. | Therapeutic and diagnostic methods |
KR101666759B1 (ko) * | 2015-08-06 | 2016-10-18 | 경북대학교 산학협력단 | 1-벤조피란메틸-1h-1,2,3-트리아졸 유도체 및 이의 용도 |
CN106632285B (zh) * | 2016-11-23 | 2019-11-01 | 河南师范大学 | 一种齐多夫定-1,2,3-三氮唑类化合物的合成方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9701453D0 (en) | 1997-01-24 | 1997-03-12 | Leo Pharm Prod Ltd | Aminobenzophenones |
DK1202957T3 (da) | 1999-07-16 | 2005-01-31 | Leo Pharma As | Aminobenzofenoner som inhibitorer for IL-1beta og TNF-alfa |
AU768473B2 (en) | 1999-07-16 | 2003-12-11 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) | Novel aminobenzophenones |
AU768512B2 (en) | 1999-07-16 | 2003-12-18 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) | Aminobenzophenones as inhibitors of IL-1beta and TNF-alpha |
US6566554B1 (en) | 1999-07-16 | 2003-05-20 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) | Aminobenzophenones as inhibitors of IL-1β and TNF-α |
AU768878B2 (en) | 1999-07-16 | 2004-01-08 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) | Aminobenzophenones as inhibitors of IL-1beta and TNF-alpha |
CN1193003C (zh) * | 1999-12-06 | 2005-03-16 | 里奥制药有限公司 | 作为IL-1β与TNF-α抑制剂的氨基二苯酮 |
AU2001260081B2 (en) | 2000-05-22 | 2005-07-28 | Leo Pharma A/S | Benzophenones as inhibitors of il-1beta and tnf-alpha |
GB0107368D0 (en) * | 2001-03-23 | 2001-05-16 | Novartis Ag | Organic compounds |
WO2002083622A2 (en) | 2001-04-10 | 2002-10-24 | Leo Pharma A/S | Novel aminophenyl ketone derivatives |
CA2458611C (en) | 2001-08-28 | 2012-05-29 | Leo Pharma A/S | Aminobenzophenones as interleukin 1-beta and tumour necrosis factor-alpha inhibitors |
PL377377A1 (pl) | 2002-12-20 | 2006-02-06 | Leo Pharma A/S | Nowe związki aminobenzofenonu |
JP4939216B2 (ja) | 2003-07-24 | 2012-05-23 | レオ ファーマ アクティーゼルスカブ | 新規アミノベンゾフェノン化合物 |
US20090313239A1 (en) | 2008-06-16 | 2009-12-17 | Microsoft Corporation | Adaptive Visual Similarity for Text-Based Image Search Results Re-ranking |
-
2005
- 2005-11-28 DK DK05804019.7T patent/DK1828148T3/da active
- 2005-11-28 DE DE602005019093T patent/DE602005019093D1/de active Active
- 2005-11-28 ES ES05804019T patent/ES2341473T3/es active Active
- 2005-11-28 BR BRPI0518993-4A patent/BRPI0518993A2/pt not_active IP Right Cessation
- 2005-11-28 RU RU2007126648/04A patent/RU2394818C2/ru not_active IP Right Cessation
- 2005-11-28 WO PCT/DK2005/000757 patent/WO2006063585A1/en active Application Filing
- 2005-11-28 CA CA002590479A patent/CA2590479A1/en not_active Abandoned
- 2005-11-28 AU AU2005316034A patent/AU2005316034B2/en not_active Ceased
- 2005-11-28 AT AT05804019T patent/ATE455768T1/de active
- 2005-11-28 ZA ZA200704809A patent/ZA200704809B/xx unknown
- 2005-11-28 CN CN2005800480385A patent/CN101115728B/zh not_active Expired - Fee Related
- 2005-11-28 KR KR1020077015959A patent/KR101260236B1/ko not_active IP Right Cessation
- 2005-11-28 MX MX2007006739A patent/MX2007006739A/es active IP Right Grant
- 2005-11-28 PL PL05804019T patent/PL1828148T3/pl unknown
- 2005-11-28 JP JP2007545836A patent/JP5015005B2/ja not_active Expired - Fee Related
- 2005-11-28 EP EP05804019A patent/EP1828148B1/en active Active
- 2005-11-28 UA UAA200707890A patent/UA90698C2/ru unknown
- 2005-11-28 PT PT05804019T patent/PT1828148E/pt unknown
- 2005-12-02 US US11/292,064 patent/US8293772B2/en not_active Expired - Fee Related
- 2005-12-12 AR ARP050105193A patent/AR051792A1/es not_active Application Discontinuation
-
2007
- 2007-05-29 IL IL183513A patent/IL183513A0/en unknown
- 2007-07-10 NO NO20073574A patent/NO20073574L/no not_active Application Discontinuation
-
2010
- 2010-04-19 HR HR20100225T patent/HRP20100225T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
KR20070095945A (ko) | 2007-10-01 |
CN101115728A (zh) | 2008-01-30 |
ZA200704809B (en) | 2008-08-27 |
AU2005316034B2 (en) | 2012-01-19 |
CN101115728B (zh) | 2012-12-19 |
MX2007006739A (es) | 2007-08-02 |
EP1828148B1 (en) | 2010-01-20 |
DK1828148T3 (da) | 2010-05-17 |
RU2007126648A (ru) | 2009-01-20 |
AR051792A1 (es) | 2007-02-07 |
ES2341473T3 (es) | 2010-06-21 |
ATE455768T1 (de) | 2010-02-15 |
UA90698C2 (en) | 2010-05-25 |
PT1828148E (pt) | 2010-05-04 |
AU2005316034A1 (en) | 2006-06-22 |
NO20073574L (no) | 2007-07-10 |
US8293772B2 (en) | 2012-10-23 |
IL183513A0 (en) | 2007-09-20 |
US20060128766A1 (en) | 2006-06-15 |
RU2394818C2 (ru) | 2010-07-20 |
KR101260236B1 (ko) | 2013-05-06 |
CA2590479A1 (en) | 2006-06-22 |
HRP20100225T1 (hr) | 2010-07-31 |
BRPI0518993A2 (pt) | 2008-12-23 |
WO2006063585A1 (en) | 2006-06-22 |
JP5015005B2 (ja) | 2012-08-29 |
DE602005019093D1 (de) | 2010-03-11 |
JP2008523115A (ja) | 2008-07-03 |
EP1828148A1 (en) | 2007-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL183513A0 (en) | Triazole substituted aminobenzophenone compounds | |
EP1737831A4 (en) | NEUROLOGICALLY ACTIVE COMPOUNDS | |
TWI369983B (en) | Compounds | |
EP1755617A4 (en) | PERFLUORCARBON-SOLUBLE COMPOUNDS | |
GB0405193D0 (en) | Compounds | |
GB0405272D0 (en) | Compounds | |
GB0405267D0 (en) | Compounds | |
GB0405101D0 (en) | Compounds | |
GB0426265D0 (en) | Compounds | |
GB0401269D0 (en) | Compounds | |
GB0405280D0 (en) | Compounds | |
HK1117152A1 (en) | Triazole substituted aminobenzophenone compounds | |
SI1828148T1 (sl) | S triazolom nadomeĺ äśeni aminobenzofenonski sestavki | |
GB0403593D0 (en) | Compounds | |
GB0403595D0 (en) | Compounds | |
GB0401657D0 (en) | Compounds | |
GB0404215D0 (en) | Compounds | |
GB0400697D0 (en) | Compounds | |
GB0427005D0 (en) | Compounds | |
GB0401653D0 (en) | Compounds | |
GB0401654D0 (en) | Compounds | |
GB0423001D0 (en) | Compounds | |
GB0403267D0 (en) | Compounds | |
GB0405936D0 (en) | Compounds | |
GB0403594D0 (en) | Compounds |